Within breast cancer cells, three markers—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)—are often used to determine the existence and concentration of cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.